The Christie NHS Foundation Trust, Manchester, UK
Mon 02 12:40
Understanding Metyrapone in Cushing's Syndrome: Mechanism of action and rationale for chronotherapy
The Christie NHS Foundation Trust, Manchester, UK
Birmingham, UK
Tue 03 13:35
Connecting Graves’ Disease and Eye Symptoms: Recognising TED Early
Birmingham, UK
Wed 04 12:30
Welcome and introductions
Birmingham, UK
Wed 04 12:35
Hypothyroidism: Management of hypothyroidism in nil by mouth, malabsorption patients and ICU settings
Birmingham, UK
Wed 04 13:15
Conclusion: Key take-home message
Birmingham, UK
Wed 04 13:20
Q&A Session
Birmingham, UK
Cardiff, UK
Cardiff, Wales
Tue 03 13:40
Munich , Germany
Genova, Italy
Wed 04 12:50
Birmingham, UK
Mon 02 12:35
What Do the New ESE Guidelines for Hypoparathyroidism Mean for Me and My Patients?
Birmingham, UK
Oxford, UK
Mon 02 12:25
The Burden and Consequences of Hypoparathyroidism
Oxford, UK
London, UK
Wed 04 12:35
Acromegaly: the treatment landscape and unmet needs
London, UK
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 02 12:55
Clinical use of Metyrapone Chronotherapy: Patient selection, safety management and clinical integration
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Queen Elizabeth Hospital, Birmingham, UK
Mon 02 12:25
When to suspect Cushing's early: Early clues and diagnostic challenges
Queen Elizabeth Hospital, Birmingham, UK
Cardiff University, United Kingdom
Sheffield, UK
Glasgow , UK
Mon 02
Yorvipath® (palopegteriparatide) From Evidence to Real World Application
Glasgow , UK
Cardiff, UK
Wed 04 12:50
Hypothyroid Emergencies: Spotting Myxoedema Coma Rapid recognition, life-saving interventions, and multidisciplinary strategies
Cardiff, UK
Wed 04 13:05
Controversies in T3/T4 & subclinical hypothyroidism
Cardiff, UK
Wed 04 13:20
Q&A Session
Birmingham, UK
Cardiff, UK
Oxford, UK
Mon 02 12:20
0 result(s) found.